Both in Pharmaceuticals
Rezolute, Inc. Common Stock (NV) vs Galectin Therapeutics
Over the past year RZLT returned −56.0% and GALT returned −7.3%; their daily moves had a correlation of -0.00.
RZLT −56.0% GALT −7.3%Growth of $1, one year, split-adjusted
| Metric | RZLT | GALT |
|---|---|---|
| Price | $4.09 | $3.91 |
| Market cap | $395.6M | $394.3M |
| Today | −2.15% | −0.51% |
| 1 month | −11.5% | −2.7% |
| 6 months | +43.5% | +52.1% |
| Year to date | +73.3% | −6.0% |
| 1 year | −56.2% | −14.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $107.8M | -$19.8M |
| Dividend yield | — | — |
| Volatility (60d) | 61.8% | 85.7% |
| Short % of float | 20.4% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).